The Argument for Performing Sentinel Lymph Node Biopsy in Thick Primary Melanomas

被引:0
作者
Joseph J. Skitzki
机构
[1] Roswell Park Comprehensive Cancer Center,Departments of Surgical Oncology and Immunology
来源
Annals of Surgical Oncology | 2023年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:7921 / 7922
页数:1
相关论文
共 26 条
[1]  
Holmberg C-J(2023)Prognostic significance of sentinel lymph node status in thick primary melanomas (>4mm) Ann Surg Oncol. 23 1378-1388
[2]  
Isaksson kk(2022)Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial Lancet Oncol. 186 166-171
[3]  
Ingvar c(2023)Has the advent of modern adjuvant systemic therapy for melanoma rendered sentinel node biopsy unnecessary? Eur J Cancer. 157 835-842
[4]  
Long GV(2022)Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial JAMA Surg. 4 1721-1728
[5]  
Luke JJ(2018)Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis JAMA Oncol. 23 579-584
[6]  
Khattak MA(2016)Sentinel lymph node biopsy in T4 melanoma: an important risk-stratification tool Ann Surg Oncol. 28 1007-1016
[7]  
Varey AHR(2021)Sentinel lymph node biopsy is prognostic in thickest melanoma cases and should be performed for thick melanomas Ann Surg Oncol. 182 163-169
[8]  
Thompson JF(2023)Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma Eur J Cancer. undefined undefined-undefined
[9]  
Howle JR(undefined)undefined undefined undefined undefined-undefined
[10]  
Lo SN(undefined)undefined undefined undefined undefined-undefined